Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Amyloidosis, Antisense, Cancer, Cardiometabolic, Cardiomyopathy, Cardiovascular Disease, Cholesterol, Clinical Trial, Diabetes, Diabetes Mellitus, Drugs, Dyslipidemia, Genes, Genetic, Genetic Disorder, High Triglycerides, Hypertriglyceridemia, Insulin, Insulin Resistance, Lipid Disorder, Lipoprotein, Metabolic Syndrome, Muscular Atrophy, Neuromuscular Disease, Pain, Pancreatitis, Placebo, Protein, RNA, Spinal Muscular Atrophy, Stomach Pain, therapeutics, Triglyceride, Type 2 Diabetes